Cautionary Statements
This Form 10-Q contains financial projections and other "forward-looking
statements," as that term is used in federal securities laws, about Grapefruit's
financial condition, results of operations and business. These statements
include, among others, statements concerning the potential for revenues and
expenses and other matters that are not historical facts. These statements may
be made expressly in this Form 10-K. You can find many of these statements by
looking for words such as "believes," "expects," "anticipates," "estimates," or
similar expressions used in this Form 10-K. These forward-looking statements are
subject to numerous assumptions, risks and uncertainties that may cause our
actual results to be materially different from any future results expressed or
implied by us in those statements. The most important facts that could prevent
us from achieving our stated goals include, but are not limited to, the
following:
(a) volatility or decline of our stock price;
(b) potential fluctuation in quarterly results;
(c) our failure to earn revenues or profits;
(d) inadequate capital to continue the business and barriers to raising the
additional capital or to obtaining the financing needed to implement our
business plans;
(e) failure to make sales;
(f) changes in demand for our products and services;
(g) rapid and significant changes in markets;
(h) litigation with or legal claims and allegations by outside parties, causing
us to incur substantial losses and expenses;
(i) insufficient revenues to cover operating costs;
(j) dilution in the ownership of the Company through the issuance by us of
additional securities and the conversion of outstanding warrants, notes and
other securities;
24
We cannot assure that we will be profitable. We may not be able to develop,
manage or market our products and services successfully. We may not be able to
attract or retain qualified executives and technology personnel. We may not be
able to obtain customers for our products or services. Our products and services
may become obsolete. Government regulation may hinder our business. Additional
dilution in outstanding stock ownership will be incurred due to the issuance or
exercise of more shares, warrants and other convertible securities.
Because the statements are subject to risks and uncertainties, actual results
may differ materially from those expressed or implied by the forward-looking
statements. We caution you not to place undue reliance on the statements, which
speak only as of the date of this Form 10-Q. The cautionary statements contained
or referred to in this section should be considered in connection with any
subsequent written or oral forward-looking statements that we or persons acting
on our behalf may make. We do not undertake any obligation to review or confirm
analysts' expectations or estimates or to release publicly any revisions to any
forward-looking statements to reflect events or circumstances after the date of
this Form 10-Q or to reflect the occurrence of unanticipated events.
The following discussion should be read in conjunction with our financial
statements and notes to those statements. In addition to historical information,
the following discussion and other parts of this annual report contain
forward-looking information that involves risks and uncertainties.
Results of Operations for the Three Months Ended September 30, 2022 as compared
to the Three Months Ended September 30, 2021.
Three months ended Three months ended
September 30, 2022 September 30, 2021
Net revenues $ 2,962 $ 153,476
Cost of goods sold 62,758 346,073
Gross income (loss) (59,796 ) (192,597 )
Sales expense 1,172 3,800
Stock based compensation 106,011 25,980
Stock option expenses 6,008 32,877
General and administrative expense 229,643 352,462
Loss from operations (402,630 ) (607,716 )
Change in value of derivatives 14,187 13,877
Interest and other expense (369,763 ) (388,273 )
Net loss before income taxes (758,207 ) (982,112 )
Tax provision - -
Net loss (758,207 ) (982,112 )
Loss attributable to noncontrolling interest - (270 )
Net loss attributable to Grapefruit USA, Inc. $ (758,207 ) $ (981,842 )
The following sets forth selected items from our statements of operations for
three months ended September 30, 2022 and for the three months ended September
30, 2021.
Revenue for the three months ended September 30, 2022 was $2,962 compared to
$153,476 for the corresponding period in 2021, a decrease of $150,514 or 98.1%.
The decrease was primarily due to the decline of our distribution business
caused by a combination of decreased demand for and an over-supply of cannabis
flowers in California. As a result of these market forces beyond our control we
have severely limited our distribution operations and commenced the process of
transitioning into a canna-biotech firm focusing on further developing and
marketing of cannabis products based on our patented Hourglass Technology. On
March 21, 2022, we received approval of our NNCP from Health Canada (NNCP ID No.
NP-V2EHUWO907) which authorizes us to manufacture and sell our Hourglass™
products throughout Canada. As the Company expands marketing efforts, we
anticipate to see additional growth.
25
Cost of goods sold for the three months ended September 30, 2022 was $62,758 as
compared to $346,073 for the corresponding period in 2021, a decrease of
$283,315, or 81.9%. Included in cost of goods sold are plant operation and other
direct overhead expenses incurred to maintain our production facilities. These
fixed carrying costs affect our gross margin more significantly at lower
revenues than at our anticipated full operating activity levels. When inspecting
inventory this quarter, we found some inventory was damaged, which necessitated
a $68,500 reduction in inventory. Most of the product was salvageable and will
be ready for resale in November 2022.
Our resulting gross loss for the three months ended September 30, 2022 was
$59,796 as compared with the gross loss of $192,597 for the corresponding period
in 2021, a decrease of $132,801, or 69.0%. The decrease was a result of the
general decrease in sales and the associated costs of goods sold.
Sales expense for the three months ended September 30, 2022 were $1,172 compared
to $3,800 for 2021, decrease of $2,628, or 69.2%. Stock based compensation for
the three months ended September 30, 2022 were $106,011 compared to $25,980 for
2021, an increase of $80,031, or 308%. Stock option expenses for the three
months ended September 30, 2022 were $6,008 compared to $32,877 for 2021, a
decrease of $26,869, or 81.7%. General and administrative expenses for the three
months ended September 30, 2022 were $229,643 compared to $352,462 for 2021, a
decrease of $122,819, or 34.8%.
Our resulting net loss from operations for the three months ended September 30,
2022 was $402,630 as compared to $607,716 for the corresponding period for 2021,
a decrease of $205,086, or 33,7%. Change in value of derivatives gain for the
three months ended September 30, 2022 was $14,187 as compared to $13,877 for
2021, a decrease of $310, or 2.2%. Interest and other expense for the three
months ended September 30, 2022 was $369,763 as compared to $388,273 for 2021, a
decrease of $18,510, or 4.8%.
Net loss for the three months ended September 30, 2022 was $758,207 as compared
to $982,112 for the corresponding period for 2021, a decrease of $223,905, or
22.8%. Loss attributable to noncontrolling interest for the three months ended
September 30, 2022 was $0 as compared to $270 the corresponding period for 2021,
a decrease of $270. Our resulting net loss attributable to Grapefruit USA, Inc.
and subsidiary for the three months ended September 30, 2022 was $758,207 as
compared to $981,842 for the corresponding period for 2021, a decrease of
$223,635, or 22.8%.
Results of Operations for the Nine Months Ended September 30, 2022 as compared
to the Nine Months Ended September 30, 2021.
Nine months ended Nine months ended
September 30, 2022 September 30, 2021
Net revenues $ 32,673 $ 586,780
Cost of goods sold 297,069 926,671
Gross income (loss) (264,396 ) (339,891 )
Sales expense 6,744 5,760
Stock based compensation 301,916 265,024
Stock option expenses 27,006 65,754
General and administrative expense 974,685 1,011,199
Loss from operations (1,574,747 ) (1,687,628 )
Change in value of derivatives 138,081 91,210
Interest and other expense (1,171,036 ) (2,149,021 )
Net loss before income taxes (2,607,702 ) (3,745,439 )
Tax provision - -
Net loss (2,607,702 ) (3,745,439 )
Loss attributable to noncontrolling interest - (270 )
Net loss attributable to Grapefruit USA, Inc. $ (2,607,702 ) $ (3,745,169 )
26
The following sets forth selected items from our statements of operations for
nine months ended September 30, 2022 and for the nine months ended September 30,
2021.
Revenue for the nine months ended September 30, 2022 was $32,673 compared to
$586,780 for the corresponding period in 2021, a decrease of $554,107 or 94.4%.
The decrease was primarily due to the decline of our distribution business
caused by a combination of decreased demand for and an over-supply of cannabis
flowers in California. As a result of these market forces beyond our control we
have severely limited our distribution operations and commenced the process of
transitioning into a canna-biotech firm focusing on further developing and
marketing of cannabis products based on our patented Hourglass Technology. On
March 21, 2022, we received approval of our NNCP from Health Canada (NNCP ID No.
NP-V2EHUWO907), which authorizes us to manufacture and sell our Hourglass™
products throughout Canada. As the Company expands marketing efforts, we
anticipate to see additional growth.
Cost of goods sold for the nine months ended September 30, 2022 was $297,069 as
compared to $926,671 for the corresponding period in 2021, a decrease of
$629,602, or 67.9%. Included in cost of goods sold are plant operation and other
direct overhead expenses incurred to maintain our production facilities. These
fixed carrying costs affect our gross margin more significantly at lower
revenues than at our anticipated full operating activity levels. When inspecting
inventory this quarter, we found some inventory was damaged, which necessitated
a $68,500 reduction in inventory. Most of the product was salvageable and will
be ready for resale in November 2022.
Our resulting gross loss for the nine months ended September 30, 2022 was
$264,396 as compared with the gross loss of $339,891 for the corresponding
period in 2021, a decrease of $75,495, or 22.2%. The decrease was a result of
the general decrease in sales and the associated costs of goods sold.
Sales expense for the nine months ended September 30, 2022 was $6,744 compared
to the $5,760 for 2021, an increase of $984, or 17.1%. Stock based compensation
for the nine months ended September 30, 2022 were $301,916 compared to $265,024
for 2021, an increase of $36,892 or 13.9%. Stock option expenses for the nine
months ended September 30, 2022 were $27,006 compared to $65,754 for 2021, a
decrease of $38,748, or 58.9%. General and administrative expense for the nine
months ended September 30, 2022 were $974,685 compared to $1,011,199 for 2021, a
decrease of $36,514, or 3.6%.
Our resulting net loss from operations for the nine months ended September 30,
2022 was $1,574,747 as compared to $1,687,628 for the corresponding period for
2021, a decrease of $112,881, or 6.7%. Change in value of derivatives gain for
the nine months ended September 30, 2022 was $138,081 as compared to $91,210 for
2021, an increase of $46,871, or 51.4%. Interest and other expense for the nine
months ended September 30, 2022 was $1,171,036 as compared to $2,149,021 for
2021, a decrease of $977,985, or 45.5%.
Net loss for the nine months ended September 30, 2022 was $2,607,702 as compared
to $3,745,439 for the corresponding period for 2021, a decrease of $1,137,737,
or 30.4%. Loss attributable to noncontrolling interest for the nine months ended
September 30, 2022 was $0 as compared to $270 for the corresponding period for
2021, a decrease of $270. Our resulting net loss attributable to Grapefruit USA,
Inc. and subsidiary for the nine months ended September 30, 2022 was $2,607,702
as compared to $3,745,169 for the corresponding period for 2021, a decrease of
$1,137,467, or 30.4%.
Liquidity and Capital Resources
Our cash position increased to $23,583 as of September 30, 2022 from $9,095 as
of December 31, 2021. Our total current assets decreased to $644,496 as of
September 30, 2021, from $714,199 as of December 31, 2021.
Our total current liabilities increased to $7,913,321 as of September 30, 2022
from $7,703,573 as of December 31, 2021.
27
During the nine months ended September 30, 2022, we used $317,552 of net cash
for operating activities, as compared to cash used by operations of $998,581
used during the nine months ended September 30, 2021. Net cash used in investing
activities during the nine months ended September 30, 2022 was $0, as compared
to $62,250 during the nine months ended September 30, 2021. Net cash provided by
financing activities during the nine months ended September 30, 2022 was
$332,040, as compared to $798,253 during the nine months ended September 30,
2021.
We expect our working capital requirements in the next year to be met primarily
by the proceeds of issuance of debt, equity and other securities to our existing
creditors, shareholders, and other investors, as well as from cash flow from
operations. We also expect that, as in the past, significant amounts of our
convertible debt with a major lender will be converted into equity. We expect to
need additional working capital from outside sources to cover our anticipated
operating expenses. There is no assurance that the Company will be able to raise
sufficient additional capital or financing to continue in business or to
effectively execute its business plan.
COVID-19 Impact
The COVID-19 pandemic has had, and continues to have, a significant impact
around the world, prompting governments and businesses to take unprecedented
measures, such as restrictions on travel and business operations, temporary
closures of businesses, and quarantine and shelter-in-place orders. The COVID-19
pandemic has at times significantly curtailed global economic activity and
caused significant volatility and disruption in global financial markets. The
COVID-19 pandemic and the measures taken by many countries in response have
affected and could in the future materially impact the Company's business,
results of operations and financial condition.
Certain of the Company's outsourcing partners, component suppliers and
logistical service providers have experienced disruptions during the COVID-19
pandemic, resulting in supply shortages. Similar disruptions could occur in the
future.
Going Concern Qualification
Our consolidated financial statements have been prepared on a going concern
basis which assumes we will be able to realize our assets and discharge our
liabilities in the normal course of business for the foreseeable future. During
the nine months ended September 30, 2022, we incurred a net loss of $2,607,703,
had a working capital deficit of $7,268,825 and had an accumulated deficit of
$19,433,867 at September 30, 2022. Our ability to continue as a going concern is
dependent upon our ability to generate profitable operations in the future and
or obtaining the necessary financing to meet our obligations and repay our
liabilities arising from normal business operations as they come due. There is
no assurance that these events will be satisfactorily completed. As a result,
there is doubt about our ability to continue as a going concern for one year
from the issuance date of these financial statements
Off-Balance Sheet Arrangements
None.
© Edgar Online, source Glimpses